Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026)
Tenaya Therapeutics (TNYA) recorded quarterly Interest & Investment Income of $793000.0 in Q1 2026, up 37.91% quarter-over-quarter from $575000.0 in Q4 2025, and up 24.88% on a YoY basis from $635000.0 in Q1 2025.
Tenaya Therapeutics (TNYA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $793000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 24.88% year-over-year to $793000.0; the TTM figure through Mar 2026 stood at $2.8 million (down 27.53% YoY), while the FY2025 annual figure was $2.7 million, down 43.38% from the prior year.
- Interest & Investment Income was $793000.0 for Q1 2026 at Tenaya Therapeutics, up from $575000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.0 million in Q1 2023 to a low of $99000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.0 million across 5 years, with a median of $815000.0 in 2025.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 2491.3% in 2022, then sank 56.27% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $1.0 million in 2022, then surged by 41.76% to $1.5 million in 2023, then slumped by 44.76% to $812000.0 in 2024, then slipped by 29.19% to $575000.0 in 2025, then jumped by 37.91% to $793000.0 in 2026.
- The last three Interest & Investment Income figures came in at $793000.0 (Q1 2026), $575000.0 (Q4 2025), and $658000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Tenaya Therapeutics | 154.33 Mn | 154.33 Mn | - | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,000.00 |
| Dec 31, 2025 | 575,000.00 |
| Sep 30, 2025 | 658,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Mar 31, 2025 | 635,000.00 |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.97 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 222,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 9,000.00 |